Autoimmunity BioSolutions
Business Services · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Houston, Texas, United StatesWebsite
www.abstherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Autoimmunity BioSolutions
ABS Therapeutics is a biotechnology company developing next-generation precision immunotherapies for autoimmune diseases. The company focuses on creating genetically targeted treatments that modulate key immune pathways to restore normal immune function in specific patient populations. Its approach combines genetic insights with therapeutic design to address unmet needs in refractory autoimmune conditions, aiming to deliver safer and more effective alternatives to traditional immunosuppressive treatments through biomarker-driven, personalized medicine.Explore more
Autoimmunity BioSolutions Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Autoimmunity BioSolutions your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Autoimmunity BioSolutions has new funding data
Congratulate Masked Content for being promoted to Masked Content at Autoimmunity BioSolutions
Check if Autoimmunity BioSolutions has recently received funding, and reach out quickly before it becomes old news!
Check out if Autoimmunity BioSolutions is spiking on competitors!
Earning: See what the market has to say on Autoimmunity BioSolutions recently announced quarterly report
Click to see if Autoimmunity BioSolutions had a recent Job posting/layoffs
Product Launch: Get notified when Autoimmunity BioSolutions launches new products
Autoimmunity BioSolutions, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Autoimmunity BioSolutions as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Autoimmunity BioSolutions is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Autoimmunity BioSolutions is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Autoimmunity BioSolutions.
Autoimmunity BioSolutions financials insights
Gather financial insights about Autoimmunity BioSolutions, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Seed
$3.1M
Autoimmunity BioSolutions Tech Stack
A closer look at the technologies used by Autoimmunity BioSolutions
Autoimmunity BioSolutions News & Media
Autoimmunity BioSolutions Expands Seed Funding
HOUSTON, TX, Autoimmunity BioSolutions, a biotechnology company developing a personalized, genetically-guided immuno-corrective therapy designed to normalize elevated levels of soluble IL7 receptor.Autoimmunity BioSolutions Expands Seed Funding Round and Deepens Family Office Participation
New Capital Positions ABS to Reach Key Clinical Milestones and Advance Its Immuno-Corrective Autoimmune Therapy Platform HOUSTON, May 13, 2026 /PRNewswire/ -- Autoimmunity BioSolutions (ABS), a biotechnology company developing a personalized, genetically-guided immuno-corrective therapy...Autoimmunity BioSolutions Bolsters Leadership Team
ABS is pioneering a personalized, genetically guided immuno-corrective therapy designed to normalize elevated levels of soluble IL7 receptor. HOUSTON, Nov. 19, 2025 /PRNewswire/ -- Autoimmunity BioSolutions (ABS), is pioneering a personalized, genetically guided immuno-corrective therapy...Mariano A. Garcia-Blanco, co-founder of Autoimmunity BioSolutions, was elected to the National Academy of Sciences
HOUSTON, May 20, 2025 /PRNewswire/ -- Autoimmunity BioSolutions (ABS), a biotechnology company pioneering targeted, immuno-corrective therapy for a highly prevalent, genetically-defined subpopulation of patients that suffer from autoimmune diseases, today announced that Dr. Mariano...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Autoimmunity BioSolutions
Sign Up For FreeTo access detailed company insights
ABS Therapeutics is a biotechnology company developing next-generation precision immunotherapies for autoimmune diseases. The company focuses on creating genetically targeted treatments that modulate key immune pathways to restore normal immune function in specific patient populations. Its approach combines genetic insights with therapeutic design... Read More
